Latest headlines
AstraZeneca PLC News
The latest AstraZeneca PLC (AZN) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these AZN headlines next to the live AstraZeneca PLC Fear and Greed Index.
Latest AstraZeneca PLC Headlines60
AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage
marketbeat.com · Jul 11, 2026
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?
cnbc.com · Jul 11, 2026
Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts
zacks.com · Jul 10, 2026
Ionis, AstraZeneca Stumble in ATTR-CM Trial as Rivals Stand to Gain
benzinga.com · Jul 10, 2026
AZN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving AstraZeneca
prnewswire.com · Jul 10, 2026
AstraZeneca Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AstraZeneca (AZN)
prnewswire.com · Jul 9, 2026
AstraZeneca And Ionis Pharma Rocked By Heart Disease Fail: Why You Shouldn't Panic
seekingalpha.com · Jul 9, 2026
AstraZeneca's Stock Drops on Wainua's Setback in ATTR-CM Study
zacks.com · Jul 9, 2026
AstraZeneca's Wainua failure hurts credibility more than valuation, Jefferies warns
proactiveinvestors.co.uk · Jul 9, 2026
5 Things to Know Before the Stock Market Opens on Thursday
investopedia.com · Jul 9, 2026
UK stocks decline as AstraZeneca tumbles after trial setback
invezz.com · Jul 9, 2026
Ionis, AstraZeneca Pivotal Heart Disease Drug Flunks
benzinga.com · Jul 9, 2026
AstraZeneca Stock and Partner Ionis Sink After Trial Failure. Alnylam Soars.
barrons.com · Jul 9, 2026
Breakfast News: AstraZeneca's Heart Drug Flatlines
fool.com · Jul 9, 2026
AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial
proactiveinvestors.com · Jul 9, 2026
AstraZeneca shares plunge as Wainua fails late-stage heart disease trial
invezz.com · Jul 9, 2026
AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial
proactiveinvestors.co.uk · Jul 9, 2026
AstraZeneca stock dives 9% after heart drug trial misses target
cnbc.com · Jul 9, 2026
AstraZeneca Says Wainua Trial Failed to Meet Primary Goal
wsj.com · Jul 9, 2026
AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial
reuters.com · Jul 9, 2026
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports
reuters.com · Jul 8, 2026
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
wsj.com · Jul 7, 2026
Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion
reuters.com · Jul 7, 2026
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
zacks.com · Jul 7, 2026
AstraZeneca PLC (AZN) Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation Transcript
seekingalpha.com · Jul 6, 2026
Citi keeps AstraZeneca on 'buy' ahead of second-quarter results
proactiveinvestors.com · Jul 6, 2026
Citi keeps AstraZeneca on 'buy' ahead of second-quarter results
proactiveinvestors.co.uk · Jul 6, 2026
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
fool.com · Jul 3, 2026
AstraZeneca PLC (AZN) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 76/100
gurufocus.com · Jul 2, 2026
Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance
benzinga.com · Jul 2, 2026
Here's Why Astrazeneca (AZN) is a Strong Value Stock
zacks.com · Jul 2, 2026
AstraZeneca signs CSPC China deal for experimental kidney disease drugs
reuters.com · Jul 2, 2026
Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
prnewswire.com · Jul 1, 2026
Why Astrazeneca (AZN) Dipped More Than Broader Market Today
zacks.com · Jul 1, 2026
AZN vs. ILMN: Which Stock Should Value Investors Buy Now?
zacks.com · Jul 1, 2026
Here's Why Astrazeneca (AZN) is a Strong Momentum Stock
zacks.com · Jul 1, 2026
AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors (Revised)
zacks.com · Jul 1, 2026
AstraZeneca's Enhertu Wins EU Nod for HER2-Positive Solid Tumors
zacks.com · Jun 29, 2026
FTSE 100 Live: London stocks fall over 100 points in broad sell-off
proactiveinvestors.com · Jun 26, 2026
Jefferies names AstraZeneca a top pick ahead of pivotal heart drug readout
proactiveinvestors.com · Jun 26, 2026
Jefferies names AstraZeneca a top pick ahead of pivotal heart drug readout
proactiveinvestors.co.uk · Jun 26, 2026
HIVE Digital Technologies upsizes convertible note offering to support GPU purchases, data center expansion
proactiveinvestors.com · Jun 26, 2026
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note
zacks.com · Jun 25, 2026
AstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer Care
businesswire.com · Jun 24, 2026
Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
zacks.com · Jun 18, 2026
The Healthcare M&A Wave
forbes.com · Jun 17, 2026
Ozempic Linked To Lower Risk Of Violence In New Study
forbes.com · Jun 17, 2026
FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiris
zacks.com · Jun 16, 2026
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
zacks.com · Jun 16, 2026
AstraZeneca's Truqap Wins FDA Nod for Prostate Cancer Indication
zacks.com · Jun 15, 2026
TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
businesswire.com · Jun 12, 2026
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
zacks.com · Jun 11, 2026
BioInvent's BI-1206 Triplet Achieves 83% Response Rate in Refractory NHL with Improved Safety vs. SOC (EHA 2026)
accessnewswire.com · Jun 11, 2026
JNJ and AZN Face Patent Headwinds: Which Stock Looks Stronger Now?
zacks.com · Jun 9, 2026
AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials
benzinga.com · Jun 9, 2026
AstraZeneca's obesity drug shows promise as analysts see upside beyond consensus
invezz.com · Jun 9, 2026
AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial
reuters.com · Jun 8, 2026
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
cnbc.com · Jun 5, 2026
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
gurufocus.com · Jun 5, 2026
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
prnewswire.com · Jun 5, 2026
Why Is AstraZeneca PLC Up or Down Today?
When AstraZeneca PLC (AZN) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a AZN move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why AstraZeneca PLC is up or down today.
How AstraZeneca PLC News Affects the Price
News does not move the AstraZeneca PLC (AZN) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the AstraZeneca PLC Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in AstraZeneca PLC trading volume. That is the chain to watch: headline, sentiment, volume, then the AZN price.
Trade the AstraZeneca PLC News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch AstraZeneca PLC trading volume spike on a big story, check the AstraZeneca PLC price history for context, follow the live AZN price, see the AstraZeneca PLC price prediction, and read the AstraZeneca PLC Fear and Greed Index for mood.
How do you feel about AstraZeneca PLC?
1DFrequently asked questions
Why is AstraZeneca PLC up or down today?
What is the latest AstraZeneca PLC news?
Where does AstraZeneca PLC news come from?
How often is AstraZeneca PLC news updated?
How does AstraZeneca PLC news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.